BD SWITZERLAND SARL
Switzerland CH-MF-000026539 Last updated 25 Oct 2026
- Devices
- 150
- Registries
- EUDAMEDFDA
- FDA recalls
- 1512 ongoing
Catalogue
Alaris Ref 80300UNS02-32
BD SmartSite™ Ref 37262E
BD MaxZero™ Ref MZ9276
BD MaxZero™ Ref MZ5309
Bodycomm Ref BODYCOMMSW-4.0
Phaseal Ref 515076
BD MaxZero™ Ref MZ5303
BD MaxZero™ Ref MZ9303
Phaseal Ref 515005
Alaris Ref 1000SP02442
BD MaxPlus™ Ref MP9027C-0006
Connecta Ref 394501
BD MaxZero™ Ref MZ9295
BD MaxZero™ Ref MZXT5304
BD MaxZero™ Ref MZX5305
BD MaxZero™ Ref MZ9321
BD MaxZero™ Ref MZ9313
BD MaxZero™ Ref MZXT5303
Alaris Ref 80223UNS02-73
Alaris Ref 80223UNS02-035
BD SmartSite™ Ref 2309E-0006
BD MaxZero™ Ref MZ9294
Connecta Ref 394926
BD SmartSite™ Ref 20041E-0006
Alaris Ref 80223UNS02-34
BD MaxZero™ Ref MZXT9001
BD MaxZero™ Ref MZ5306
Alaris Ref 80300UNS01-70
Phaseal Ref 515067
Phaseal Optima Ref 515053
BD MaxZero™ Ref MZ9324
Alaris Ref 80300UNS02-54
Phaseal Ref 515303
BD SmartSite™ Ref 20049E7D
BD MaxZero™ Ref MZ9290
BD MaxZero™ Ref MZ5312
Connecta Ref 394961
Connecta Ref 395095
Alaris Ref 80300UNS02-52
BD MaxZero™ Ref MZ9278
Alaris Ref 80300UNS01-32
Texium Ref MY8005-0006
BD SmartSite™ Ref 2202E-0006
Alaris Ref 80223UNS02-54
Alaris Ref 80300UNS02-73
Connecta Ref 395061
Texium Ref 10012241
BD MaxZero™ Ref MZ5301
Alaris Ref 80300UNS01-54
Alaris Ref 80300UNS02-30
Showing 1-50 of 150
EUDAMED certificates
Notified body 2797 1 certificate
- MDR 745680 Supplemented
Quality management system EU MDR
- Issued
- 27 Jul 2026
- Expires
- 3 Sep 2028
- Reason
- Change approved
Related companies
Notified bodies
- Notified body 2797
FDA recalls
2026
- 19 Aug 2026 Z-3080-2026 Class I Ongoing Due to discrepancies in specific attributes in the performance data for infusion sets, which may lead to inappropriate pump performance.
- 16 Jun 2026 Z-2941-2026 Class II Ongoing Due to mechanical issue with internal sterilization equipment resulting in potential underdosing of product during processing, which may have resulted in products not being sterilized correctly.
- 4 Jun 2026 Z-2654-2026 Class II Ongoing Due to engineering sample labeled "Not for Human Use" being inadvertently shipped it the U.S. market.
- 21 May 2026 Z-2514-2026 Class II Ongoing Due to stopcock issues when using the plastic luer-lok syringe, the connection at the Port C may over thread or continue to spin rather than tightening securely. This behavior has led some clinical users to perceive the connection as unstable.
2025
- 16 Jun 2025 Z-2453-2025 Class II Ongoing Closed system drug transfer devices were shipped to the U.S. market without a U.S. version of the instructions for use, which could be an issue if a healthcare professional is prompted to review it.
- 12 May 2025 Z-1970-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
- 12 May 2025 Z-1971-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
- 12 May 2025 Z-1972-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
- 12 May 2025 Z-1973-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
- 12 May 2025 Z-1974-2025 Class II Ongoing Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may cause procedure delay, treatment interruptions, exposure to hazardous drugs, and/or underdosing of medication.
Show all 15 recalls
2025
- 20 Feb 2025 Z-1509-2025 Class II Ongoing Due to specific lots of luer-lok devices were shipped to the U.S. market with an Outside US Instruction for Use (IFU)
2024
- 18 Apr 2024 Z-1944-2024 Class II Ongoing Due to infusion set tubing drip chamber becoming detached from the tubing potentially causing delays in treatment, or unintentionally exposing users to harsh infusates.
2020
- 9 Apr 2020 Z-1967-2020 Class II Terminated The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.
- 9 Apr 2020 Z-1968-2020 Class II Terminated The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.
- 9 Apr 2020 Z-1969-2020 Class II Terminated The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.
Information
- Country
- Switzerland
- Address
- 17, Route de Crassier, Eysins, Switzerland
- Website
- www.bd.com
- [email protected]
- Phone
- +41 21 556 30 00
- PRRC contact
- Michael Campbell
- EUDAMED SRN
- CH-MF-000026539
- FDA FEI number
- 3012798826